Australian Clinical Labs Ltd (ASX:ACL)

Last updated

Position & Order Advice

    [dvmd_table_maker tbl_column_header_count=”0″ _builder_version=”4.14.5″ _module_preset=”default” width_tablet=”” width_phone=”” width_last_edited=”on|phone” max_width=”100%” module_alignment=”left” hover_enabled=”0″ global_colors_info=”{}” disabled_on=”on|on|on” disabled=”on” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Name” col_content=”Date
    Buy Limit Price ($)
    Open Position
    Stop Loss ($)
    Target Price ($)” col_tcell_cell_align_horz=”right” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Values” col_content=”15-Sep-21
    4.40
    1,000
    4.50
    6.75″ col_tcell_cell_align_horz=”right” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][/dvmd_table_maker]

    First profit target reached – 50% of position closed

    by | Dec 23, 2021

    In early trading today the ACL share price reached an all-time high of $6.10. The first profit target to sell 50% of the high conviction’s reports position being 1,000 shares at $5.95 was reached. As a result, we sold 1,000 shares locking in a nice profit on part of...

    Open Position Trade Blotter

    All positions use a hypothetical position size and is not a advice on the recommended trade size. This is done to calculate the dividend and franking credits.

     

     Closed Positions Trade History

    All positions use a hypothetical position size and is not a advice on the recommended trade size. This is done to calculate the dividend and franking credits.

    [dvmd_table_maker tbl_row_header_count=”0″ tbl_responsive_break_by=”row” tbl_stripes_active=”on” tbl_stripes_order=”odd” tbl_chead_cell_align_horz=”center” _builder_version=”4.14.5″ _module_preset=”default” tbl_chead_text_font=”|||on|||||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Date” col_content=”Date
    15-Sep-21
    22-Dec-21
    01-Feb-22″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”B/S” col_content=”B/S
    BUY
    SELL
    SELL” col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Qty” col_content=”Qty
    2,000
    1,000
    1,000″ col_icon_type=”=||divi||400″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Price ($)” col_content=”Price ($)
    4.40
    5.95
    5.07″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Total ($)” col_content=”Total ($)
    8,800.00
    5,950.00
    5,070.00″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Notes” col_content=”Notes” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][/dvmd_table_maker]
    [dvmd_table_maker tbl_column_header_count=”0″ disabled_on=”off|off|off” _builder_version=”4.14.5″ _module_preset=”default” width_tablet=”” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” module_alignment=”right” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Name” col_content=”Dividends ($)
    Franking Cr. ($)
    Capital Rtn ($)
    Realised Rtn ($)
    Realised Rtn (%)” col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Values” col_content=”-
    –
    2,220
    2,220
    25.23″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][/dvmd_table_maker]

    Recommendation History

    Initial Entry – Undervalue Pathology Business

    by | Sep 15, 2021

    Today we have identified what we believe is an undervalued company on the ASX that is a long term beneficiary of the Covid-19 virus. The company is Australian clinical Labs (ACL) the third largest provider of pathology services in Australia ACL is a relatively new...

    Share This